Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.
about
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of ThroMulticenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension.Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension.Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
P2860
Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical features of patients ...... icated by portal hypertension.
@ast
Clinical features of patients ...... icated by portal hypertension.
@en
type
label
Clinical features of patients ...... icated by portal hypertension.
@ast
Clinical features of patients ...... icated by portal hypertension.
@en
prefLabel
Clinical features of patients ...... icated by portal hypertension.
@ast
Clinical features of patients ...... icated by portal hypertension.
@en
P2093
P2860
P1476
Clinical features of patients ...... licated by portal hypertension
@en
P2093
Ehab Atallah
Florence Wong
Holly Geyer
Jeannie Callum
Justyna Bartoszko
Manjula Maganti
Ruben Mesa
P2860
P356
10.1016/J.CLML.2014.04.004
P407
P577
2014-06-11T00:00:00Z